关注
Fares Elghali
Fares Elghali
其他姓名Elghali Fares
Centre of Biotechnology of Sfax-Tunisa
在 fss.u-sfax.tn 的电子邮件经过验证
标题
引用次数
引用次数
年份
Lambda-cyhalothrin exposure alters purine nucleotide hydrolysis and nucleotidase gene expression pattern in platelets and liver of rats
B Aouey, E Fares, Y Chtourou, M Bouchard, H Fetoui
Chemico-Biological Interactions 311, 108796, 2019
162019
Three Component One-Pot Synthesis and Antiproliferative Activity of New [1,2,4]Triazolo[4,3-a]pyrimidines
M Ben Hassen, D Msalbi, B Jismy, F Elghali, S Aifa, H Allouchi, M Abarbri, ...
Molecules 28 (9), 3917, 2023
122023
Benzochromenopyrimidines: Synthesis, Antiproliferative Activity against Colorectal Cancer and Physicochemical Properties
E Choura, F Elghali, PJ Bernard, D Msalbi, J Marco-Contelles, S Aifa, ...
Molecules 27 (22), 7878, 2022
42022
Unveiling the impact of selected essential oils on MRSA strain ATCC 33591: antibacterial efficiency, biofilm disruption, and staphyloxanthin inhibition
F Elghali, I Ibrahim, M Guesmi, F Frikha, S Mnif
Brazilian Journal of Microbiology 55 (3), 2057-2069, 2024
32024
Synthesis and Biological Evaluation of New Benzochromenopyrimidines for the Therapy of Colon and Lung Cancer
E Choura, F El Ghali, PJ Bernard, J Marco‐Contelles, S Aifa, L Ismaili, ...
ChemistrySelect 9 (2), e202303632, 2024
32024
Evaluation of Antibacterial Activity in Some Algerian Essential Oils and Selection of Thymus vulgaris as a Potential Biofilm and Quorum Sensing Inhibitor Against Pseudomonas …
FZ Mohammed Aggad, F Ilias, F Elghali, R Mrabet, IA El Haci, S Aifa, ...
Chemistry & Biodiversity, e202402691, 2025
2025
Evaluation of the Combinatory Anticancer Effect of Chemotherapeutic Compounds and Prodigiosin against HCT-116, LoVo, and A549 Cell lines
F Elghali, D Msalbi, F Frikha, M Alonazi, E Sahli, B Hakim, S Mnif, ...
ACS omega 9 (49), 48112-48124, 2024
2024
An improved anticancer effect of 5-fluorouracil (5-FU) in combination with Prodigiosin
F ELGHALI, D MSALBI, E SAHLI, B HAKIM, MS AIFA
2023
系统目前无法执行此操作,请稍后再试。
文章 1–8